If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
Proceeds to be used to develop first-in-class arginase inhibitors for cardiovascular and pulmonary indications BALTIMORE, MD, Oct., 2–(HSMN NewsFeed)–Arginetix, Inc. today announced it has closed a $10.75 million Series A financing. The company is dev…
Biopharmaceuticals, Venture Capital
Arginetix
Posts on ‘October 1st, 2009’
Arginetix Closes $10.75 Million Series A Financing
Verathon(R) Helps Physicians Identify the Presence of Abdominal Aortic Aneurysms with New AortaScan(TM) Brand of Portable Ultrasound Aortic Measurement Instruments
BOTHELL, Wash., Oct. 1 (HSMN NewsFeed) — Verathon® is pleased to announce the new AortaScan(TM) AMI 9700 aortic measurement instrument to help physicians identify the presence of abdominal aortic aneurysms (AAA). Designed with Emergency Physicians, …
Devices
Verathon, AortaScan, AMI 9700, AAA, ultrasound
Wound Management Technologies Acquires Resorbable Orthopedics
Specialty Clinical Products Company Enters $10 Billion Orthopedic Biomaterials Market with Patented Technologies FORT WORTH, Texas, Oct. 1 (HSMN NewsFeed) — Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM ) a rapidly growing provider of…
Devices, Wound Care, Orthopaedic, Acquisitions
Wound Management Technologies
Astellas and Theravance Announce Approval of VIBATIV(TM) (telavancin) in Canada for the Treatment of Complicated Skin and Skin Structure Infections
VIBATIV(TM) Approved for the Treatment of cSSSI Caused by Susceptible Gram-positive Bacteria, Including MRSA and MSSA Strains MARKHAM, ON and SOUTH SAN FRANCISCO, CA., Oct., 1 — (HSMN NewsFeed) - Astellas Pharmaceutical Canada, Inc. (Astellas) and Theravance, …
Biopharmaceuticals, Regulatory
Theravance, Astellas Pharmaceutical Canada, VIBATIV, telavancin, cSSSI, MRSA
